Andres McAllister
Vermögen: 7 139 $ am 31.08.2026
Vermögen: 7 139 $ am 31.08.2026
Andres McAllister is currently Chief Medical Officer at BioInvent International AB since 2017.
Former positions include Director-Research & Development at Immune Design Corp., Non-Executive Director at Immunexpress Pty Ltd., Principal at Institut Pasteur, Chief Scientific Officer at Debiopharm International SA from 2004 to 2015, Principal at The University of California, San Francisco, and Principal at Centre d'Immunologie Pierre Fabre.
Education includes doctorates from Université Paris 1 Panthéon-Sorbonne and Universidad del Rosario.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.12.2025 | 3’009 ( 0% ) | 7 139 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOINVENT INTERNATIONAL AB | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2017 |
| Unternehmen | Position | Ende |
|---|---|---|
Debiopharm International SA
Debiopharm International SA BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops drugs to cure cancer and infectious diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2015 |
Immunexpress Pty Ltd.
Immunexpress Pty Ltd. Medical SpecialtiesHealth Technology Engages in creating molecular diagnostics for sepsis | Direktor/Vorstandsmitglied | - |
Centre d'Immunologie Pierre Fabre | Corporate Officer/Principal | - |
Institut Pasteur
Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Corporate Officer/Principal | - |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
BioInvent International AB
BioInvent International AB BiotechnologyHealth Technology Develops and manufactures immunomodulatory antibodies for cancer treatment | Health Technology |
Institut Pasteur
Institut Pasteur Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Debiopharm International SA
Debiopharm International SA BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops drugs to cure cancer and infectious diseases | Health Technology |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Paris 1 Panthéon-Sorbonne
Université Paris 1 Panthéon-Sorbonne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immune Design Corp.
Immune Design Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical and clinical-stage immunotherapy company | Health Technology |
Immunexpress Pty Ltd.
Immunexpress Pty Ltd. Medical SpecialtiesHealth Technology Engages in creating molecular diagnostics for sepsis | Health Technology |
Universidad del Rosario
Universidad del Rosario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Centre d'Immunologie Pierre Fabre |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen